Cleared Traditional

K880887 - NEOCATH

K880887 is an FDA 510(k) clearance for NEOCATH, manufactured by Taris Corp.. The device is a Class 2 Cardiovascular device with product code DWF cleared through the Traditional 510(k) pathway after a 83-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1988
Decision
83d
Days
Class 2
Risk

K880887 is an FDA 510(k) clearance for the NEOCATH. Classified as Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (product code DWF), Class II - Special Controls.

Submitted by Taris Corp. (Fernandina Beach, US). The FDA issued a Cleared decision on May 24, 1988 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Taris Corp. devices

FDA 510(k) Submission Details - K880887

510(k) Number K880887 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 02, 1988
Decision Date May 24, 1988
Days to Decision 83 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 125d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DWF Device Classification - Class 2, Special Controls

Product Code DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

All 345
Devices cleared under the same product code (DWF) and FDA review panel - the closest regulatory comparables to K880887.
SHILEY FEMORAL ARTERIAL CANNULA
K881072 · Shiley, Inc. · May 1988
SHILEY FEMORAL VENOUS CANNULA
K881074 · Shiley, Inc. · May 1988
8.5 FR. PESCUTANEOUS SHEATH INTRODUCER SYSTEM
K880777 · Medsurg Industries, Inc. · May 1988
MEDSURG 16 GA. CENTRAL VEIN CATHETERIZATION TRAY
K880779 · Medsurg Industries, Inc. · May 1988
DESCENDING ARCH CANNULA
K880421 · Dlp, Inc. · Apr 1988
PERCUTANEOUS ARTERIAL/VENOUS CANNULA PLACEMENT KIT
K875353 · Dlp, Inc. · Mar 1988